Quotient Sciences | December 15, 2022
Exhibitor News
HighTide Therapeutics and Quotient Sciences Announce Agreement to Conduct a 14C Human ADME Program for HTD1801
Emplicure AB and Quotient Sciences Announce an Integrated Manufacturing and Clinical Testing Partnership for Emplicure’s First Clinical Pharmacokinetic Study for EMPLI03
Quotient Sciences | November 29, 2022
Quotient Sciences Completes Major Expansion of Drug Substance Manufacturing Facility
Quotient Sciences | October 17, 2022
DYCEM PRESS KIT
Dycem Ltd. | October 12, 2022